Skip Nav Destination
Issues
15 May 2005
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
The Biology Behind
Report from the FDA
Human Cancer Biology
In vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models
Sang Hoon Lee; Daniel Lopes de Menezes; Jayesh Vora; Alex Harris; Helen Ye; Lara Nordahl; Evelyn Garrett; Emil Samara; Sharon Lea Aukerman; Arnold B. Gelb; Carla Heise
Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance
Sayaka Otake; Hiroaki Takeda; Yasukuni Suzuki; Tadahisa Fukui; Shinichiro Watanabe; Katsuyoshi Ishihama; Takafumi Saito; Hitoshi Togashi; Tadashi Nakamura; Yuji Matsuzawa; Sumio Kawata
Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis
Qianren Jin; Kari Hemminki; Kerstin Enquist; Per Lenner; Ewa Grzybowska; Rüdiger Klaes; Roger Henriksson; Bowang Chen; Jolanta Pamula; Wioletta Pekala; Helena Zientek; Jadwiga Rogozinska-Szczepka; Beata Utracka-Hutka; Göran Hallmans; Asta Försti
Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma
Gema Mateo; Mariana Castellanos; Ana Rasillo; Norma C. Gutiérrez; Ma. Angeles Montalbán; Ma. Luisa Martín; Jesús Ma. Hernández; Ma. Consuelo López-Berges; Laura Montejano; Joan Bladé; Ma. Victoria Mateos; Anna Sureda; Javier de la Rubia; Joaquín Díaz-Mediavilla; Atanasio Pandiella; Juan José Lahuerta; Alberto Orfao; Jesús F. San Miguel
Imaging, Diagnosis, Prognosis
Analysis of KIT Mutations in Sporadic and Familial Gastrointestinal Stromal Tumors: Therapeutic Implications through Protein Modeling
Chi Tarn; Erin Merkel; Adrian A. Canutescu; Wei Shen; Yuliya Skorobogatko; Martin J. Heslin; Burton Eisenberg; Ruth Birbe; Arthur Patchefsky; Roland Dunbrack; J. Pablo Arnoletti; Margaret von Mehren; Andrew K. Godwin
Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers
Andrew Berchuck; Edwin S. Iversen; Johnathan M. Lancaster; Jennifer Pittman; Jingqin Luo; Paula Lee; Susan Murphy; Holly K. Dressman; Phillip G. Febbo; Mike West; Joseph R. Nevins; Jeffrey R. Marks
Evaluation of a Panel of Tumor Markers for Molecular Detection of Circulating Cancer Cells in Women with Suspected Breast Cancer
Monica M. Reinholz; Andrea Nibbe; Leslie M. Jonart; Kathleen Kitzmann; Vera J. Suman; James N. Ingle; Raymond Houghton; Barbara Zehentner; Patrick C. Roche; Wilma L. Lingle
Mutation in the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor Is a Predictive and Prognostic Factor for Gefitinib Treatment in Patients with Non–Small Cell Lung Cancer
Teh-Ying Chou; Chao-Hua Chiu; Ling-Hui Li; Chun-Yen Hsiao; Chin-Yuan Tzen; Kuo-Ting Chang; Yuh-Min Chen; Reury-Perng Perng; Shih-Feng Tsai; Chun-Ming Tsai
Prognostic Role of Thymidylate Synthase Polymorphisms in Gastric Cancer Patients Treated with Surgery and Adjuvant Chemotherapy
Kazuyuki Kawakami; Francesco Graziano; Go Watanabe; Annamaria Ruzzo; Daniele Santini; Vincenzo Catalano; Renato Bisonni; Federica Arduini; Italo Bearzi; Stefano Cascinu; Pietro Muretto; Giuseppe Perrone; Carla Rabitti; Lucio Giustini; Giuseppe Tonini; Francesca Pizzagalli; Mauro Magnani
Cyclooxygenase-2 Overexpression Is Associated with a Poor Outcome in Resected Ampullary Cancer Patients
Daniele Santini; Bruno Vincenzi; Giuseppe Tonini; Susanna Scarpa; Fortunata Vasaturo; Carolina Malacrino; Fabio Vecchio; Domenico Borzomati; Sergio Valeri; Roberto Coppola; Paolo Magistrelli; Gennaro Nuzzo; Aurelio Picciocchi
Cancer Therapy: Clinical
Phase I and Pharmacokinetic Study of the Dolastatin 10 Analogue TZT-1027, Given on Days 1 and 8 of a 3-Week Cycle in Patients with Advanced Solid Tumors
Maja J.A. de Jonge; Ate van der Gaast; André S.T. Planting; Leny van Doorn; Aletta Lems; Inge Boot; Jantien Wanders; Masahiko Satomi; Jaap Verweij
A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol
Manish A. Shah; Jeremy Kortmansky; Monica Motwani; Marija Drobnjak; Mithat Gonen; Sandy Yi; Amanda Weyerbacher; Carlos Cordon-Cardo; Robert Lefkowitz; Baruch Brenner; Eileen O'Reilly; Leonard Saltz; William Tong; David P. Kelsen; Gary K. Schwartz
A Phase II, Pharmacokinetic, and Biological Correlative Study of Oblimersen Sodium and Docetaxel in Patients with Hormone-Refractory Prostate Cancer
Anthony W. Tolcher; Kim Chi; John Kuhn; Martin Gleave; Amita Patnaik; Chris Takimoto; Garry Schwartz; Ian Thompson; Kristin Berg; Susan D'Aloisio; Nevin Murray; Stanley R. Frankel; Elzbieta Izbicka; Eric Rowinsky
Cancer Therapy: Preclinical
Plasma Pharmacokinetics, Oral Bioavailability, and Interspecies Scaling of the DNA Methyltransferase Inhibitor, Zebularine
Julianne L. Holleran; Robert A. Parise; Erin Joseph; Julie L. Eiseman; Joseph M. Covey; Elizabeth R. Glaze; Alexander V. Lyubimov; Ya-Fei Chen; David Z. D'Argenio; Merrill J. Egorin
A Neutralizing Anti–Fibroblast Growth Factor 8 Monoclonal Antibody Shows Potent Antitumor Activity against Androgen-Dependent Mouse Mammary Tumors In vivo
Naoki Shimada; Toshihiko Ishii; Teruyoshi Imada; Katsumi Takaba; Yuka Sasaki; Kumiko Maruyama-Takahashi; Yoshimi Maekawa-Tokuda; Hideaki Kusaka; Shiro Akinaga; Akira Tanaka; Kenya Shitara
Frequent Immune Responses to a Cancer/Testis Antigen, CAGE, in Patients with Microsatellite instability–Positive Endometrial Cancer
Takashi Iwata; Tomonobu Fujita; Nobumaru Hirao; Yuriko Matsuzaki; Tsutomu Okada; Hiroshi Mochimaru; Nobuyuki Susumu; Eri Matsumoto; Kokichi Sugano; Naohide Yamashita; Shiro Nozawa; Yutaka Kawakami
Letters to the Editor
Corrections
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.